{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:24:51Z","timestamp":1787840691197,"version":"build-2784847793"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"\n Background:<\/jats:title>\n Pyelonephritis is the most common bacterial infection in children that can cause renal failure if not diagnosed or treated early. We used serum biomarker interleukins (IL-6 and IL-8) and then confirmed the results by the findings dimercaptosuccinic acid (DMSA) scan to distinguish upper-tract infection from lower-tract infection.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Serum IL-6 and IL-8 were measured in 57 children with newly diagnosed untreated urinary tract infection (UTI) documented by a positive urine culture. All children had a DMSA to determine whether serum IL6, IL-8 can be used as a marker to predict upper-tract from lower-tract infection. IL-6 and IL8 were determined by the enzyme link immunosorbent assay (ELISA) technique.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Of the 57 patients, 24 (42%) had renal parenchymal lesions on the DMSA scan. Patients with abnormal DMSA had significantly higher serum IL-6 and IL-8 compared with those with normal DMSA scan (187.1 \u00b1 113.1 ng\/mL vs. 396.1 \u00b1 246.0 ng\/mL,\n P<\/jats:italic>\n = 0.005; and 165 \u00b1 76.1 ng\/mLvs. 190.8 \u00b1 60.8 ng\/mL,\n P<\/jats:italic>\n = 0.026, respectively). Pyelonephritis was more frequent in children younger than 20 months old (\n n<\/jats:italic>\n = 36, 63%,\n P<\/jats:italic>\n < 0.005) and more prevalent in girls (\n n<\/jats:italic>\n = 36, 63%,\n P<\/jats:italic>\n = 0.005). Serum IL-6 had a sensitivity of 67.3% and a specificity of 63.0% and serum IL8 had a sensitivity of 80.1% and a specificity of 73.5% in the differential diagnosis of pyelonephritis and cystitis (\n P<\/jats:italic>\n = 0.03).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n Serum levels of IL-6 and IL-8 are both sensitive biomarkers of UTI and can discriminate the upper from lower tract urinary infections. Determination of these biomarkers may help to identify patients with acute pyelonephritis and need for DMSA study.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijpvm.ijpvm_50_19","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T15:48:42Z","timestamp":1611071322000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Serum Interleukin-6 and Interleukin-8 are Sensitive Markers for Early Detection of Pyelonephritis and Its Prevention to Progression to Chronic Kidney Disease"],"prefix":"10.4103","volume":"12","author":[{"given":"Mojgan","family":"Mazaheri","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Section of Nephrology, Semnan University of Medical Sciences, Semnan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"R1-20250812","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0891-5520(03)00005-9","article-title":"Epidemiology of urinary tract infections: Transmission and risk factors, incidence, and costs","volume":"17","author":"Foxman","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"R2-20250812","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/MOP.0b013e32835c14cc","article-title":"Update on recent guidelines for the management of urinary tract infections in children: The shifting paradigm","volume":"25","author":"Paintsil","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"R3-20250812","first-page":"185","article-title":"overview of the evaluation, diagnosis, and management of urinary tract infections in infants and children","volume":"25","author":"Dulczak","year":"2005","journal-title":"Urologist Nurs"},{"key":"R4-20250812","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1542\/pir.2017-0007","article-title":"Urinary btractrial infections in children","volume":"39","author":"Balighian","year":"2018","journal-title":"Pediatr Rev"},{"key":"R5-20250812","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1542\/peds.2011-1330","article-title":"Clinical practice guidelines for the diagnosis and management of the initial; UTI in febrile infants and children 2 to 24 months","volume":"128","year":"2011","journal-title":"Pediatrics"},{"key":"R6-20250812","first-page":"5","article-title":"The value of Tc99m-DMSA renal scintigraphy in evaluation of severity of parenchyma lesions in children with acute urinary tract infection","volume":"57","author":"Puseljic","year":"2003","journal-title":"Acta Med Croatica"},{"key":"R7-20250812","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s00467-007-0465-7","article-title":"Diagnostic significance of clinical and laboratory findings to localize site of urinary infection","volume":"22","author":"Garin","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"R8-20250812","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF02725654","article-title":"Elevated levels of secretory immunoglobulin A (sIgA) in urinary tract infections","volume":"71","author":"Deo","year":"2004","journal-title":"Indian J Pediatr"},{"key":"R9-20250812","first-page":"1","article-title":"Heparin-binding protein: A. diagnostic biomarker of urinary tract infection in adults","author":"Kjolvmark","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"R10-20250812","first-page":"283","article-title":"Alpha 1-microglobin as a marker of proximal tubular in urinary tract infection in children","volume":"53","author":"Mantur","year":"2000","journal-title":"Clin Nephrol"},{"key":"R11-20250812","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0009-8981(83)90304-2","article-title":"N-acetyl-beta-D-glucosaminidase (NAG) isoenzyme in children with upper and Lower urinary tract infections","volume":"130","author":"Vigano","year":"1983","journal-title":"Clin Chim Acta"},{"key":"R12-20250812","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11255-008-9472-2","article-title":"Procalcitonin for the early prediction of renal parenchymal involment in children with UTI: Preliminary results","volume":"41","author":"Kotoula","year":"2009","journal-title":"Int Urol Nephrol"},{"key":"R13-20250812","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00467-005-1941-6","article-title":"Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis","volume":"20","author":"Gurgoze","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"R14-20250812","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4137\/BMI.S3155","article-title":"Novel biomarkers for the diagnosis of urinary tract infection-a systemic review","volume":"4","author":"Nanda","year":"2009","journal-title":"Biomark Insights"},{"key":"R15-20250812","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s15010-001-1157-z","article-title":"Urine interleukin-8 is a marker for urinary tract infection in postoperative patients","volume":"29","author":"Olszyna","year":"2001","journal-title":"Infection"},{"key":"R16-20250812","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1590\/S1677-5538.IBJU.2016.0049","article-title":"The combination of urinary IL-6 and renal biometry as useful diagnostic tools to differentiate acute pyelonephritis from lower urinary tract infection","volume":"42","author":"Azab","year":"2016","journal-title":"Int Braz J Urol"},{"key":"R17-20250812","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cyto.2007.02.006","article-title":"Serum and urine levels of interleukin-6 and interleukin-8 in children with acute pyelonephritis","volume":"36","author":"Sheu","year":"2006","journal-title":"Cytokine"},{"key":"R18-20250812","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1136\/bmj.319.7223.1492","article-title":"Calculating the number needed to treat for trials where the outcome is time to event","volume":"319","author":"Altman","year":"1999","journal-title":"BMJ"},{"key":"R19-20250812","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1523-1755.2005.00381.x","article-title":"Chemokine response to febrile urinary tract infection","volume":"68","author":"Otto","year":"2005","journal-title":"Kidney Int"}],"container-title":["International Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpvm.IJPVM_50_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:27:11Z","timestamp":1787837231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpvm.IJPVM_50_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijpvm.ijpvm_50_19","relation":{},"ISSN":["2008-7802","2008-8213"],"issn-type":[{"value":"2008-7802","type":"print"},{"value":"2008-8213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"2019-02-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}